10-12 September 2018 //  Lancaster Royal Hotel, London

Adaptive Biotechnologies

Adaptive Biotechnologies, Associate Sponsor at Cell & Gene Therapy Europe

Adaptive Biotechnologies combines high-throughput sequencing and expert bioinformatics to profile T-cell and B-cell receptors of the adaptive immune system. Adaptive is bringing the accuracy and sensitivity of its immunosequencing platform into laboratories worldwide to drive groundbreaking research, therapeutic development and clinical diagnostics in cancer and other immune-mediated diseases to improve patient care.

2017 Speakers

"It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance."

Bertrand Alexandre, Director, Marketing Europe, Celyad